Neck Rhabdoid Tumors: Clinical Features and Consideration of Autologous Stem Cell Transplant

Adam D. Wolfe, Christian M. Capitini, Shahriar M. Salamat, Kenneth DeSantes, Kristin A. Bradley, Tabassum Kennedy, Louis P. Dehner, Neha J. Patel

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Summary: Extrarenal malignant rhabdoid tumors (MRT) have a poor prognosis despite aggressive therapy. Adding high-dose chemotherapy with autologous stem cell rescue (HDC-ASCR) as consolidative therapy for MRT is controversial. We describe 2 patients, age 13 years and 19 months, with unresectable neck MRT. After chemotherapy and radiotherapy, both underwent HDC-ASCR and remain in remission over 4 years later. We reviewed all published cases of neck MRT, and found poorer outcomes and more variable age of presentation and time to progression than MRT at other sites. Neck MRT may represent a higher-risk subset of MRT, and addition of HDC-ASCR merits consideration.

Original languageEnglish
Pages (from-to)e50-e54
JournalJournal of Pediatric Hematology/Oncology
Volume40
Issue number1
DOIs
StatePublished - 2018

Keywords

  • Atypical teratoid rhabdoid tumor
  • High-dose chemotherapy with autologous stem cell rescue
  • Malignant rhabdoid tumor

Fingerprint

Dive into the research topics of 'Neck Rhabdoid Tumors: Clinical Features and Consideration of Autologous Stem Cell Transplant'. Together they form a unique fingerprint.

Cite this